Ewing's sarcoma.

被引:7
作者
Meyers P.A. [1 ]
Levy A.S. [1 ]
机构
[1] Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, 10021, NY
关键词
Ifosfamide; Main Drug Interaction; Mesna; Secondary Malignancy; Hemorrhagic Cystitis;
D O I
10.1007/s11864-000-0036-7
中图分类号
学科分类号
摘要
Patients with Ewing's sarcoma should be transferred to a comprehensive cancer center for evaluation and management when the diagnosis is suspected. Proper biopsy technique is essential to preserve all therapeutic options, including limb preservation surgery. In addition to conventional histologic examination, biopsy tissue must be obtained for molecular biology studies. Demonstration of the consistent chromosomal translocation associated with Ewing's sarcoma is essential for diagnosis, and the specific type of fusion transcript has prognostic implications. Treatment must be intimately coordinated among oncologist, surgeon, and radiation oncologist. Successful treatment requires systemic, multi-agent chemotherapy and local control. The primary tumor can be treated with surgery, radiation therapy, or a combination of the two. The choice of modality should be dictated by the age of the patient, location of the primary tumor, functional consequences of the intervention, and concern about late effects, especially secondary malignancy. Treatment of the patient who presents with clinically detectable metastatic disease or who relapses after initial therapy remains unsatisfactory and controversial.
引用
收藏
页码:247 / 257
页数:10
相关论文
共 54 条
[1]  
Delattre O(1994)The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts N Engl J Med 331 294-299
[2]  
Zucman J(1997)Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors Cancer Genet Cytogenet 97 12-19
[3]  
Melot T(1992)Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors Genes Chromosomes Cancer 5 30-34
[4]  
Desmaze C(1993)EWS rearrangement in Ewing’s sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression Diagn Mol Pathol 2 141-146
[5]  
Brizard F(1994)Improved outcome in nonmetastatic Ewing’s sarcoma (EWS) and PNET of bone with the addition of ifosfamide (I) and etoposide (E) to vincristine (V), Adriamycin (Ad), cyclophosphamide (C), and actinomycin (A): a Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) report Proc Am Soc Clin Oncol 13 A1443-A1443
[6]  
Turc-Carel C(1996)Metastatic Ewing’s sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bone; failure of new regimens to improve outcome Proc Am Soc Clin Oncol 15 A1472-A1472
[7]  
Desmaze C(1992)No benefit of ifosfamide in Ewing’s sarcoma: a nonrandomized study of the French Society of Pediatric Oncology J Clin Oncol 10 1407-1412
[8]  
Zucman J(1995)Very-highdose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing’s sarcoma, in children and young adults J Clin Oncol 13 2796-2804
[9]  
Delattre O(1984)The management of Ewing’s sarcoma: role of radiotherapy in local tumor control Cancer Treat Rep 68 703-710
[10]  
Ladanyi M(1991)Radiation therapy as local treatment in Ewing’s sarcoma. Results of the Cooperative Ewing’s Sarcoma Studies CESS 81 and CESS 86 Cancer 67 2818-2825